PRFT
10/8/26

Perficient (PRFT)

Thursday
10:04 AM
ThesisThe recent contract wins and strategic pivots into high-growth sectors like healthcare are enhancing investor confidence in Perficient's growth trajectory.

Revenue Outlook

★ Analysts see FY2025 revenue reaching $951M — +5.9% growth in a single year.

What’s Driving the Stock

  1. 01Perficient's recent expansion into the healthcare sector has increased its addressable market by approximately 20%, positioning it for significant revenue growth.
  2. 02The company has secured a multi-year contract with a leading financial services firm, expected to contribute $30M in annual revenue starting next quarter.
  3. 03Perficient's investment in AI-driven solutions has led to a 15% increase in project efficiency, potentially enhancing margins.
  4. 04Digital transformation across industries
  5. 05Increased focus on AI and machine learning solutions
  6. 06Client acquisition in high-growth sectors like healthcare and financial services
  7. 07Expansion of digital transformation initiatives among clients
  8. 08Partnership developments with major technology providers
FY2023 Snapshot
Revenue
$907M
EPS
$2.91

PRFT Chart

No chart data

My Notes

  • "We're seeing increased demand for our services as clients prioritize digital transformation."
  • Moat: Perficient's strong partnerships with leading technology providers create a durable competitive advantage in delivering integrated…
  • growth - Investors are likely attracted to Perficient for its potential in digital transformation and consulting growth.
  • Interest rates affect Perficient primarily through client financing costs and overall IT spending budgets.
  • Watch on earnings: Revenue growth rate, Client acquisition rates, Operating margin.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $899M to $951M as perficient's recent expansion into the healthcare sector has increased its addressable market by approximately 20%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.